DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Medical - Instruments & Supplies

Healthcare
$8.52 +1.84%

+$0.19 today

Market cap
$1.70B
Beta
0.91
P/E (TTM)
-3.3
EPS (TTM)
-$3.14
Dividend yield
6.27%
52W Low $9.41High $17.09

Volume 5.40M

Average 4.70M

XRAY Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

DENTSPLY SIRONA Inc.NASDAQ: XRAY

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow turns negative

Q1 FY2026 financing cash flow was -$119M, compared with $123M a year earlier. Trailing-twelve-month financing cash flow was -$322M. Over 3 fiscal years it compounded at -37.6% a year.

Context

  • Financing cash flow amounted to 2.2% of revenue in FY2025, down 5.8 pp from a year earlier.
  • Financing cash flow grew in size in 0 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near -$119M or moves back toward the trailing-twelve-month quarterly average of -$80.5M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$119M+20.2% QoQ
Last fiscal yearDec 2025
-$80M-73.5% YoY
LTMMar 2026
-$322M+95.2% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-196.7%——
1 year-73.5%——
3-year CAGR-37.6%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(80M) USD
Year-over-year change
+73.5%

Financing Cash Flow vs competitors

How XRAY compares with its peers on the latest reported figures

  • XRAY's LTM Mar 2026 financing cash flow of $322M is the 2nd largest of the 4 companies compared; the peer median is $277.1M.
  • Its year-over-year change of +95.2% is the 2nd highest of 4, against a peer median of -44.1%.
  • Financing cash flow amounts to 8.7% of revenue for XRAY, versus a peer median of 2.8%.
XRAY Competitors Peer median
Financing Cash Flow for XRAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSICHenry Schein, Inc.LTM Jun 2026$381M +632.7%-29.4%2.8%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$322M +95.2%-37.6%8.7%
ALGNAlign Technology, Inc.LTM Jun 2026$277.1M -44.1%-2.5%6.7%
NVSTEnvista Holdings CorpLTM Oct 2026$25.2M -82.8%—0.9%
Peer median (excluding XRAY) $277.1M-44.1%-15.9%2.8%

Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income411M(950M)(132M)(910M)(598M)
Depreciation & Amortization346M328M343M349M352M
Deferred Income Tax(25M)(228M)(130M)(136M)30M
Stock-Based Compensation48M59M46M39M33M
Change in Working Capital(126M)(78M)(89M)95M(222M)
Accounts Receivables(117M)85M(58M)104M(91M)
Inventory(64M)(141M)6M17M(17M)
Accounts Payables(49M)30M14M(30M)11M
Other Working Capital104M(52M)(51M)4M(125M)
Other Non-Cash Items3M1.39B339M1.02B640M
Operating Cash Flow657M517M377M461M235M
Capital Expenditures(142M)(149M)(149M)(180M)(131M)
Acquisitions (Net)(220M)013M00
Purchases of Investments00000
Sales of Investments2M13M000
Other Investing Activities2M(2M)47M(17M)(1M)
Investing Cash Flow(358M)(138M)(89M)(197M)(132M)
Debt Repayment(102M)(60M)119M90M54M
Common Stock Issued00000
Common Stock Repurchased(200M)(150M)(300M)(250M)0
Dividends Paid(92M)(104M)(116M)(126M)(128M)
Other Financing Activities15M(15M)(10M)(16M)(6M)
Financing Cash Flow(379M)(329M)(307M)(302M)(80M)
Effect of Forex Changes(19M)(24M)(12M)(24M)31M
Net Change in Cash(99M)26M(31M)(62M)54M
Free Cash Flow515M368M228M281M104M

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Intrinsic Alpha fair value

Locked

Current Price

$8.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.